A doctor and a patient in consultation, reviewing a single-lead ECG on a Tricog CardioCheck device.

Detect cardiovascular
risk in seconds

TCC reads a quick single-lead ECG and gives you a Low, Moderate or High risk category in seconds. Makes it easy to decide what to do next with each patient.

Trusted by healthcare teams delivering earlier
cardiac intervention.

Clinical Validation

Built and Validated on Real-World ECG Data

Developed using millions of ECG recordings collected across hospitals and clinics in India, and validated on independent patient cohorts not used during model development.

Millions of ECG recordings
Diverse populations
Independent validation cohorts
0.909
AUROC
Area Under the Receiver Operating Characteristic curve
85.9%
Sensitivity
High-risk detection
92.2%
Specificity
Accuracy in ruling out high risk
90.2%
Sensitivity
True low-risk identified

Want the detail? Full methodology, confidence intervals and risk-class definitions are set out in the validation whitepaper.

Request the Full Validation Report
The Gap

The gap is detection,
not treatment

Healthcare systems know how to treat cardiac disease. The larger challenge is finding people before they become patients. Many remain unaware of their risk and therefore never reach a doctor until it is too late.

110 million

Indians live with cardiovascular disease today a number set to more than double by 2050.

1 in 4

deaths in India are due to heart disease.

About 1 in 5

of the world's cardiac deaths happen in India.

Detected

The few who get diagnosed.

Undetected

The millions who don’t..

How TCC is different

Built for clinical screening, not consumer monitoring

Conventional approaches concentrate on patients with symptoms, known risk factors, or clinical suspicion.TCC enables large-scale screening during routine healthcare interactions, creating more opportunities to detect cardiac conditions earlier.

Tricog CardioCheck
ECG in Watch
Traditional Triage
Other 1-Lead ECGs
Who it's for Every patient at the clinic Consumer smartwatch users Only patients a doctor suspects People who already know they have a condition
What it looks for Findings across Low / Moderate / High Risks AFib + irregular rhythm Depends on symptoms 4 rhythms only
What you get back A clear risk level + the next step A rhythm alert A judgement call A rhythm label
Fits the vitals workflow
Yes, adds ~30–50s
X X X
Cardiologist on site
Not needed
X Required X
Time to result ~10s (after a 30-sec ECG) X X X
Device OMRON Complete (only) Consumer smartwatch 12-lead machine Own device
Regulatory CDSCO-certified, Class B SaMD Consumer X Consumer
In the flow of a normal visit

Fits the existing outpatient workflow.

A patient checking in with a clinician at a front desk
01

Check in as usual.

Patients visit healthcare providers for a wide range of reasons. By embedding screening into routine interactions, TCC helps identify potential cardiac conditions that might otherwise remain unnoticed.

A patient checking in with a clinician at a front desk
02

During routine vitals.

A 30-second ECG is captured using the OMRON Complete device alongside routine BP, SpO₂, height, and weight measurements. The patient places their fingers on the pads and remains still for 30 seconds. The ECG is taken as part of the same routine visit, without adding another step for the patient.

A patient checking in with a clinician at a front desk
03

A result in seconds.

A Low, Moderate or High risk level is displayed on the staff member’s phone, providing an immediate indication for the next step in care.

A patient checking in with a clinician at a front desk
04

A clear next step.

Low: Continue routine care.
Moderate or High: Refer for a 12-lead ECG and clinical review.

June 2025. A village clinic outside Bengaluru.

400+ People Screened. One Seamless Path from Screening to Clinical Care.

Read the story

Everything the clinician needs at the point of care

Request a Live Demo

The output is a structured triage signal that arrives while the patient is still in front of you.

Risk Category: Low, Moderate or High
Clinical Insights: The waveform patterns that drove the classification
Referral Guidance: The recommended next action (12-lead ECG and clinical review when indicated)

Cardiac Disease Screening at Scale Quick AI-Based Triaging Zero Workflow Change Aids Clinical Decision Support

Where CardioCheck is used

The same 30-second capture, adapted to your setting from high-volume OPDs to rural health centres.

High-volume OPD
Large Hospitals High volume

Screens every patient at intake without slowing the queue, so priority follows cardiac risk, not arrival order.

Corporate screening
Corporate screening Large cohorts

Adds a cardiac risk category to routine check-ups for asymptomatic patients who may otherwise be missed by conventional screening.

Rural PHC
Rural PHC No cardiologist on site

With no cardiologist on site, frontline staff get an objective basis for referral.

GP clinic
GP clinic No diagnostics onsite

Single-doctor practices with no diagnostics get a structured way to decide who to refer onward.

Health camps
Health camps Portable & fast

Portable and usable by non-specialist staff, with the risk category available immediately.

Know more

Questions, answered.

Tricog CardioCheck is an AI-powered cardiovascular risk triage algorithm that uses a single-lead ECG to support risk stratification at scale. Designed for use across healthcare settings and digital platforms, TCC helps identify patients who may be at cardiovascular risk and could otherwise be missed through traditional clinical pathways. It supports clinicians in determining which patients may need further evaluation or follow-up.
A single-lead ECG is a quick, 30-second recording of the heart’s electrical activity. It captures clinically relevant ECG signals that can help identify potential cardiac risk. TCC analyzes this ECG using its algorithm to assess the patient’s cardiovascular risk and classify it as Low, Moderate, or High.
TCC enables a single-lead ECG to be used not just to capture a signal but also as a screening tool to help flag patients who may otherwise be missed in the traditional clinical pathway.
No. TCC is a cardiac risk screening and triage tool, not a diagnostic tool.
A High Risk result indicates that the patient may require further cardiac evaluation. The patient should be referred to a doctor for clinical assessment and, where appropriate, a 12-lead ECG and further evaluation as soon as possible.

TCC does not diagnose a cardiac condition. The final assessment and next steps are determined by the treating clinician based on the patient’s symptoms, history, examination, and other clinical findings.
TCC currently supports ECG data recorded using OMRON Healthcare’s Complete™ blood pressure monitors with integrated ECG monitoring.

Through our partnership with OMRON Healthcare, ECG data captured by these devices is securely transmitted to the cloud and analyzed by the TCC algorithm to provide a Low, Moderate, or High cardiovascular risk assessment in approximately 10 seconds.
Yes. TCC is designed with healthcare data privacy and security in mind and complies with applicable HIPAA, GDPR, and CDSCO requirements. Access to patient information is restricted based on authorized roles, helping ensure that sensitive health data is only available to those who need it.
No. TCC does not replace a traditional 12-lead ECG. TCC is a rapid cardiac risk screening tool designed to help identify patients who may need further cardiac evaluation.

A 12-lead ECG provides a more comprehensive assessment of the heart’s electrical activity and may be recommended by a clinician following a TCC result, based on the patient’s symptoms, history, and clinical findings.
TCC was developed using a foundational dataset of millions of ECG recordings, with training designed to account for class imbalance so that less common, high-risk cardiac patterns were adequately represented.

TCC is also validated on separate ECG data to assess how reliably it identifies different levels of cardiac risk.
No. TCC does not replace a cardiologist or traditional clinical diagnosis. It is designed to work alongside clinical judgment by analysing single-lead ECGs and providing risk stratification into low, moderate and high risk.

The output should be considered in consultation with a qualified healthcare professional.
TCC is not intended for:

  • People below 18 years of age
  • Pregnant women
  • Patients with pacemakers
  • Patients with Implantable Cardioverter Defibrillators (ICDs)
Yes. Tricog CardioCheck is a CDSCO-certified Software as a Class-B Medical Device (SaMD).
With Tricog CardioCheck you get quick risk detection, a clear triage pathway and efficient patient flow
Watch how it works